Brief: Biosergen Says US FDA Grants BSG005 Orphan Drug Status

Biosergen AB

28/06/2021 06:40

June 28 (Reuters) - Biosergen AB  BIOSGN.ST :
    * SAID ON SUNDAY BIOSERGEN'S ANTIFUGAL DRUG BSG005 IS
GRANTED
ORPHAN DRUG STATUS IN THE UNITED STATES
    * FDA GRANTED BSG005, CO'S ANTIFUNGAL DRUG OF POLYENE
MACROLIDE
CLASS, ORPHAN DRUG STATUS IN THE UNITED STATES

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr4wmDD1
    
 Further company coverage:  BIOSGN.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))